Finanical Statements
Arab Pharmaceuticals (ADCI.CA) Reports Its Financial Results for the Period From 01/07/2025 to 31/03/2026
Published at 21 May 2026 at 11:48Arab PharmaceuticalsRelated stock:Arab Pharmaceuticals stockAll Arab Pharmaceuticals disclosures
Disclosure summary
Company Name: Arab Pharmaceuticals
ISIN Code: EGS38321C013
Currency: Egyptian Pound
F/S Period: From 01/07/2025 to 31/03/2026
Net profit: 196,370,734
F/S Period: From 01/07/2024 to 31/03/2025
Net Comparative profit: 164,674,528
Audit Status: Reviewed
Source: Arab Pharmaceuticals
The Financial Statements (1,199 KB)
ISIN Code: EGS38321C013
Currency: Egyptian Pound
F/S Period: From 01/07/2025 to 31/03/2026
Net profit: 196,370,734
F/S Period: From 01/07/2024 to 31/03/2025
Net Comparative profit: 164,674,528
Audit Status: Reviewed
Source: Arab Pharmaceuticals
The Financial Statements (1,199 KB)